The WACC of An Phat Bioplastics JSC (AAA.VN) is 10.2%.
Range | Selected | |
Cost of equity | 10.70% - 16.10% | 13.40% |
Tax rate | 18.40% - 20.30% | 19.35% |
Cost of debt | 5.30% - 14.50% | 9.90% |
WACC | 7.0% - 13.5% | 10.2% |
Category | Low | High |
Long-term bond rate | 2.7% | 3.2% |
Equity market risk premium | 9.5% | 10.5% |
Adjusted beta | 0.83 | 1.18 |
Additional risk adjustments | 0.0% | 0.5% |
Cost of equity | 10.70% | 16.10% |
Tax rate | 18.40% | 20.30% |
Debt/Equity ratio | 1.41 | 1.41 |
Cost of debt | 5.30% | 14.50% |
After-tax WACC | 7.0% | 13.5% |
Selected WACC | 10.2% | |
The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.
This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.
Here’s how we figure out the cost of equity for AAA.VN:
cost_of_equity (13.40%) = risk_free_rate (2.95%) + equity_risk_premium (10.00%) * adjusted_beta (0.83) + risk_adjustments (0.25%)
We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.